![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ADAMTS4 |
Gene summary for ADAMTS4 |
![]() |
Gene information | Species | Human | Gene symbol | ADAMTS4 | Gene ID | 9507 |
Gene name | ADAM metallopeptidase with thrombospondin type 1 motif 4 | |
Gene Alias | ADAMTS-2 | |
Cytomap | 1q23.3 | |
Gene Type | protein-coding | GO ID | GO:0001501 | UniProtAcc | O75173 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9507 | ADAMTS4 | P2T-E | Human | Esophagus | ESCC | 2.28e-09 | 1.51e-01 | 0.1177 |
9507 | ADAMTS4 | P8T-E | Human | Esophagus | ESCC | 1.10e-02 | -3.07e-02 | 0.0889 |
9507 | ADAMTS4 | P10T-E | Human | Esophagus | ESCC | 2.84e-03 | 3.79e-03 | 0.116 |
9507 | ADAMTS4 | P16T-E | Human | Esophagus | ESCC | 1.58e-10 | 1.40e-01 | 0.1153 |
9507 | ADAMTS4 | P21T-E | Human | Esophagus | ESCC | 9.18e-05 | 1.41e-02 | 0.1617 |
9507 | ADAMTS4 | P24T-E | Human | Esophagus | ESCC | 7.05e-04 | 7.96e-02 | 0.1287 |
9507 | ADAMTS4 | P52T-E | Human | Esophagus | ESCC | 6.64e-21 | 5.49e-01 | 0.1555 |
9507 | ADAMTS4 | P56T-E | Human | Esophagus | ESCC | 5.22e-09 | 1.81e+00 | 0.1613 |
9507 | ADAMTS4 | P76T-E | Human | Esophagus | ESCC | 2.76e-02 | 1.47e-01 | 0.1207 |
9507 | ADAMTS4 | P80T-E | Human | Esophagus | ESCC | 4.08e-11 | 8.34e-01 | 0.155 |
9507 | ADAMTS4 | P130T-E | Human | Esophagus | ESCC | 5.21e-09 | 1.77e-01 | 0.1676 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![]() | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0022411111 | Esophagus | ESCC | cellular component disassembly | 305/8552 | 443/18723 | 1.94e-23 | 4.57e-21 | 305 |
GO:00301984 | Esophagus | ESCC | extracellular matrix organization | 171/8552 | 301/18723 | 6.08e-05 | 4.67e-04 | 171 |
GO:00430624 | Esophagus | ESCC | extracellular structure organization | 171/8552 | 302/18723 | 7.73e-05 | 5.76e-04 | 171 |
GO:00452294 | Esophagus | ESCC | external encapsulating structure organization | 172/8552 | 304/18723 | 7.80e-05 | 5.80e-04 | 172 |
GO:00226172 | Esophagus | ESCC | extracellular matrix disassembly | 39/8552 | 63/18723 | 6.92e-03 | 2.52e-02 | 39 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ADAMTS4 | SNV | Missense_Mutation | c.1126N>T | p.Pro376Ser | p.P376S | O75173 | protein_coding | tolerated(0.56) | benign(0.003) | TCGA-CK-5916-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
ADAMTS4 | SNV | Missense_Mutation | c.614C>T | p.Pro205Leu | p.P205L | O75173 | protein_coding | tolerated(0.07) | benign(0.001) | TCGA-CM-4743-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | capecitabine | SD | |
ADAMTS4 | SNV | Missense_Mutation | c.2264G>T | p.Gly755Val | p.G755V | O75173 | protein_coding | deleterious(0) | probably_damaging(0.993) | TCGA-CM-5861-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
ADAMTS4 | SNV | Missense_Mutation | c.65C>T | p.Pro22Leu | p.P22L | O75173 | protein_coding | tolerated_low_confidence(0.75) | benign(0) | TCGA-F4-6856-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Ancillary | leucovorin | CR | |
ADAMTS4 | SNV | Missense_Mutation | novel | c.2390N>C | p.Arg797Pro | p.R797P | O75173 | protein_coding | deleterious(0) | probably_damaging(0.932) | TCGA-NH-A50V-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | CR |
ADAMTS4 | SNV | Missense_Mutation | c.466C>T | p.Arg156Trp | p.R156W | O75173 | protein_coding | deleterious(0.03) | possibly_damaging(0.892) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
ADAMTS4 | SNV | Missense_Mutation | novel | c.836C>A | p.Pro279His | p.P279H | O75173 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-AG-A01J-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ADAMTS4 | SNV | Missense_Mutation | rs780697413 | c.1778N>A | p.Arg593His | p.R593H | O75173 | protein_coding | tolerated(0.27) | benign(0.125) | TCGA-DT-5265-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ADAMTS4 | insertion | Frame_Shift_Ins | novel | c.472_473insG | p.Ala158GlyfsTer2 | p.A158Gfs*2 | O75173 | protein_coding | TCGA-AA-3663-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | ||
ADAMTS4 | insertion | Frame_Shift_Ins | novel | c.472_473insG | p.Ala158GlyfsTer2 | p.A158Gfs*2 | O75173 | protein_coding | TCGA-AA-3715-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 9 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
9507 | ADAMTS4 | ENZYME, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, PROTEASE | CHONDROITIN SULFATE | 14701864 | ||
9507 | ADAMTS4 | ENZYME, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, PROTEASE | 1607004-34-1 | |||
9507 | ADAMTS4 | ENZYME, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, PROTEASE | inhibitor | 252166754 | ||
9507 | ADAMTS4 | ENZYME, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, PROTEASE | US9206139, 4 | |||
9507 | ADAMTS4 | ENZYME, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, PROTEASE | US9206139, 5 |
Page: 1 |